The future of the global digital PCR and quantitative PCR market looks promising with opportunities in the hospital & diagnostic center, research laboratories & academic institute, pharmaceutical & biotechnology company, clinical research organization, and forensic laboratory markets. The global digital PCR and quantitative PCR market is expected to reach an estimated $5.8 billion by 2030 with a CAGR of 6.0% from 2024 to 2030. The major drivers for this market are strict regulations pertaining to clinical trials, medication development, and genetic testing, PCR operations are being revolutionized by advances in automation and robotics, as well as, expansion of molecular biology applications in genomics and personalized medicines around the globe.

Some of the Key Questions answered in this exclusive report are:

Q.1. What are some of the most promising, high-growth opportunities for the digital PCR and quantitative PCR market by product type (quantitative PCR and digital PCR), application (clinical applications, research applications, pathogen testing, oncology testing, blood screening, and others), end use (hospitals & diagnostic centers, research laboratories & academic institutes, pharmaceutical & biotechnology companies, clinical research organizations, and forensic laboratories), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3.  Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6.  What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Market Segmentation:

In this market, clinical application, research application, pathogen testing, oncology testing, and blood screening are the major segments of digital PCR and quantitative PCR market by application. Lucintel forecasts that clinical will remain the largest segment over the forecast period due to the evolving PCR landscape, spurred by rising demand in clinical contexts.

Within this market, research laboratories & academic institute is expected to witness the highest growth because these institutions drive innovation in the field by developing new applications, protocols, and instrumentation for dPCR and qPCR.

North America will remain the largest region over the forecast period due to favourable regulations, government attempts to expand healthcare infrastructure, and the region's high illness prevalence.

Bio Rad Laboratories, Thermo Fisher Scientific, Qiagen, F. Hoffmann La Roche, Abbott Laboratories, Agilent Technologies, BD, Danaher, Merck, and Takara Bio are the major suppliers in the digital PCR and quantitative PCR market